France Pharmaceuticals & Healthcare Report Q1 2016 - New Market Research Report

The uptick in private consumption and economic growth in France will benefit the pharmaceutical and healthcare sector through the coming quarters. However, despite an improving regional and domestic economic environment, France's pharmaceutical market growth is expected to remain in negative territory in 2016, before it resumes expansion. Meanwhile, fixed investment rates are also expected to recover in 2016, although structural impediments will continue to hinder a more significant upturn in activity in the near term, including in the pharmaceutical sector.

Headline Expenditure Projections

Pharmaceuticals: EUR33.69bn (USD45.14bn) in 2014 to EUR33.46bn (USD36.80bn) in 2015; -0.7% in local currency terms and -18.5% in US dollar terms. Forecast in line with last quarter.
Healthcare: EUR246.20bn (USD329.91bn) in 2014 to EUR253.47bn (USD278.82bn) in 2015; +3.0% in local currency terms and -15.5% in US dollar terms. Forecast in line with last quarter.

Full Report Details at
- http://www.fastmr.com/prod/1109849_france_pharmaceuticals.aspx?afid=301

The France Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's France Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the France pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's pharmaceutical and healthcare market forecasts for France, to test other views - a key input for successful budgeting and strategic business planning in the French pharmaceutical and healthcare market.
* Target business opportunities and risks in the French pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in France.
* Assess the activities, strategy and market position of your competitors using our company profiles (including SWOTs, KPIs and latest activity) and competitive landscape tables.

Coverage

BMI Industry View

An at-a-glance perspective on the latest regulatory developments, key forecast indicators and major corporate developments, covering the prescription, OTC and generics markets. The pharmaceuticals and healthcare SWOT outlines strategic factors that affect the basic assumptions underpinning BMI’s forecast analysis, and taken together with BMI’s political, economic and business environment SWOTs, it gives a complete overview of market climate.

BMI Industry Forecast Scenario

Industry forecasts to end-2019 for all key indicators, supported by explicit assumptions, plus analysis of key downside risks to the main forecasts:

* Healthcare:

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Saudi Arabia Pharmaceuticals & Healthcare Report Q1 2016
- Kenya Pharmaceuticals & Healthcare Report Q1 2016
- Ukraine Pharmaceuticals & Healthcare Report Q1 2016
- Thailand Pharmaceuticals & Healthcare Report Q1 2016
- Bangladesh Pharmaceuticals & Healthcare Report Q1 2016